Labcorp Holdings Inc.

LH trades at a 22.3 P/E while its RSI sits at a notably depressed 36.4, suggesting the stock has been under meaningful selling pressure despite maintaining a $21.5B market cap. The 3.95% short float is modest, so a squeeze appears unlikely. With the stock trading below its 52-week high and momentum indicators flashing oversold conditions, the valuation—neither cheap nor expensive relative to healthcare services peers—reflects a market caught between caution and recovery potential. The setup hints at a floor being tested rather than a collapse underway.